NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated August 1, 2026

Supplement × Prescription·Evidence index

Atorvastatin and Vitamin B3: what the published research says

PubMed indexes 3 records that name Atorvastatin and Vitamin B3 together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.

Read this first

An evidence index, not guidance.

Every statement below is attributed to a named, dated, linked source.

This page lists published research relevant to Atorvastatin and Vitamin B3. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.

The research

3 studies naming Atorvastatin and Vitamin B3.

Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.

Combination treatment with atorvastatin plus niacin provides effective control of complex dyslipidemias: a literature review.

Postgraduate medicine · 2012 · PMID 22314110

ReviewHuman subjects

“Overall, the studies were small but indicated that atorvastatin in combination with niacin was efficacious in normalizing lipid parameters. Larger lipid studies as well as studies evaluating cardiovascular outcomes during atorvastatin plus niacin treatment are warranted.”

McKenney · From the abstract

Names both Atorvastatin and Vitamin B3 in its title.

A population-based treat-to-target pharmacoeconomic analysis of HMG-CoA reductase inhibitors in hypercholesterolemia.

Clinical therapeutics · 1999 · PMID 10321422

Meta-AnalysisHuman subjects

“In adapting the findings on cholesterol-lowering efficacy from this analysis to our lipid clinic, we concluded that the most cost-effective treatment approach is to individualize the selection of an HMG-CoA reductase inhibitor based on both coronary risk and the LDL-C reduction required to achieve NCEP ATP-II goals. Based on our results, 2 agents--atorvastatin and fluvastatin--should be available on the formulary.”

Hilleman et al. · From the abstract

Names Atorvastatin and Vitamin B3 together in an interaction, co-administration, or pharmacokinetic context.

Comparison table: Some lipid-lowering drugs.

The Medical letter on drugs and therapeutics · 2019 · PMID 30845107

Comparative StudyHuman subjects

Names Atorvastatin and Vitamin B3 together in an interaction, co-administration, or pharmacokinetic context.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Atorvastatin, Vitamin B3, and several hundred other substances.

The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.